Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine. - ND

• Conditions: Essential arterial hypertension; MedDRA version: 9.1Level: LLTClassification code 10020775

• Registration Number: EUCTR2010-020945-28-IT
• Lead Sponsor: INSTITUT DE RECHERCHES INTERNATIONALES SERVIER

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-12-17
• Last Update Posted: 18 March 2013

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

- Outpatients, - Men or women, - 18 years old at least, - Mild to moderate hypertensive patient.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Pregnant or breastfeeding women, - Secondary hypertension, - Any patient suffering from an acute or chronic illness.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified